• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过测量与急性早幼粒细胞白血病相关的弥散性血管内凝血中稳定交联纤维蛋白降解产物来表征纤溶状态。

Characterization of the fibrinolytic state by measuring stable cross-linked fibrin degradation products in disseminated intravascular coagulation associated with acute promyelocytic leukemia.

作者信息

Okajima K, Koga S, Okabe H, Inoue M, Takatsuki K

机构信息

Department of Laboratory Medicine, Kumamoto University Medical School, Japan.

出版信息

Acta Haematol. 1989;81(1):15-8. doi: 10.1159/000205392.

DOI:10.1159/000205392
PMID:2494830
Abstract

Plasma samples from patients with disseminated intravascular coagulation (DIC) associated with acute promyelocytic leukemia (APL) exhibited higher levels of the D-fragment of fibrin and fibrinogen degradation products [FDP(D)], with relatively lower levels of cross-linked fibrin degradation products (XDP), than samples of DIC with non-APL. The difference between FDP(D) and XDP levels increased only when alpha 2-plasmin inhibitor (alpha 2-PI) fell below 60% of the normal level in APL patients. These findings suggest that fibrinogenolysis occurs in APL patients when the alpha 2-PI level has decreased significantly.

摘要

与急性早幼粒细胞白血病(APL)相关的弥散性血管内凝血(DIC)患者的血浆样本,相较于非APL的DIC样本,显示出更高水平的纤维蛋白和纤维蛋白原降解产物的D片段[FDP(D)],而交联纤维蛋白降解产物(XDP)水平相对较低。仅当APL患者的α2 - 纤溶酶抑制剂(α2 - PI)降至正常水平的60%以下时,FDP(D)和XDP水平之间的差异才会增大。这些发现表明,当α2 - PI水平显著降低时,APL患者会发生纤维蛋白原溶解。

相似文献

1
Characterization of the fibrinolytic state by measuring stable cross-linked fibrin degradation products in disseminated intravascular coagulation associated with acute promyelocytic leukemia.通过测量与急性早幼粒细胞白血病相关的弥散性血管内凝血中稳定交联纤维蛋白降解产物来表征纤溶状态。
Acta Haematol. 1989;81(1):15-8. doi: 10.1159/000205392.
2
[Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].[3例急性早幼粒细胞白血病合并弥散性血管内凝血患者FDP片段的研究]
Rinsho Byori. 1993 Jun;41(6):719-25.
3
Fibrinolysis and fibrinogenolysis in disseminated intravascular coagulation.弥散性血管内凝血中的纤维蛋白溶解和纤维蛋白原溶解
Thromb Haemost. 1990 Jun 28;63(3):340-4.
4
Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.与急性早幼粒细胞白血病相关的凝血障碍:全反式维甲酸治疗的纠正作用。
Leukemia. 1993 Jan;7(1):2-9.
5
Characterization of fibrin/fibrinogen degradation products reagents and their utility in critical care patients with enhanced fibrinolysis.纤维蛋白/纤维蛋白原降解产物试剂的特性及其在伴有纤维蛋白溶解增强的重症监护患者中的应用。
Int J Lab Hematol. 2021 Aug;43(4):813-820. doi: 10.1111/ijlh.13428. Epub 2020 Dec 10.
6
[Intravascular coagulation in acute promyelocytic leukemia: analysis of coagulation and fibrinolysis parameters].[急性早幼粒细胞白血病中的血管内凝血:凝血与纤维蛋白溶解参数分析]
Rev Med Chil. 1991 Sep;119(9):984-9.
7
Elastase mediated fibrinolysis in acute promyelocytic leukemia.急性早幼粒细胞白血病中弹性蛋白酶介导的纤维蛋白溶解作用
Thromb Haemost. 2000 Jun;83(6):906-8.
8
Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.使用分子标志物研究弥散性血管内凝血中凝血与纤溶之间的平衡
Blood Coagul Fibrinolysis. 1994 Oct;5(5):829-32. doi: 10.1097/00001721-199410000-00022.
9
[Progress in diagnosis of disseminated intravascular coagulation (DIC)--diagnostic criteria of DIC].[弥散性血管内凝血(DIC)的诊断进展——DIC的诊断标准]
Nihon Rinsho. 1993 Jan;51(1):43-9.
10
[Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].[弥散性血管内凝血(DIC)中的凝血与纤维蛋白溶解参数]
Rinsho Byori. 1991 Mar;39(3):309-14.

引用本文的文献

1
Hemorrhage in acute promyelocytic leukemia-fibrinolysis in focus.急性早幼粒细胞白血病中的出血——聚焦于纤维蛋白溶解
Res Pract Thromb Haemost. 2024 Jul 2;8(5):102499. doi: 10.1016/j.rpth.2024.102499. eCollection 2024 Jul.
2
Phenotypes of Disseminated Intravascular Coagulation.弥漫性血管内凝血的表型。
Thromb Haemost. 2024 Mar;124(3):181-191. doi: 10.1055/a-2165-1142. Epub 2023 Sep 1.
3
Hemostatic alterations in cancer patients.
Cancer Metastasis Rev. 1992 Nov;11(3-4):237-48. doi: 10.1007/BF01307180.